Cigna Group $CI Shares Sold by Boston Partners

Boston Partners trimmed its position in shares of Cigna Group (NYSE:CI) by 1.7% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 407,227 shares of the health services provider’s stock after selling 6,977 shares during the quarter. Boston Partners’ holdings in Cigna Group were worth $134,444,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in CI. Valeo Financial Advisors LLC increased its holdings in Cigna Group by 86,071.1% in the second quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock valued at $1,148,859,000 after buying an additional 3,471,249 shares in the last quarter. Nuveen LLC acquired a new stake in shares of Cigna Group during the 1st quarter valued at about $727,905,000. Price T Rowe Associates Inc. MD increased its stake in shares of Cigna Group by 10.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock valued at $3,966,690,000 after purchasing an additional 1,094,327 shares in the last quarter. GQG Partners LLC increased its stake in shares of Cigna Group by 21.5% in the 1st quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock valued at $1,607,716,000 after purchasing an additional 865,092 shares in the last quarter. Finally, Goldman Sachs Group Inc. raised its holdings in Cigna Group by 38.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,649,837 shares of the health services provider’s stock worth $542,796,000 after purchasing an additional 457,052 shares during the period. 86.99% of the stock is owned by hedge funds and other institutional investors.

Cigna Group Trading Up 3.7%

Shares of CI opened at $267.82 on Wednesday. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00. The stock has a market cap of $71.54 billion, a PE ratio of 14.62, a price-to-earnings-growth ratio of 0.88 and a beta of 0.44. The firm’s fifty day moving average is $291.71 and its two-hundred day moving average is $302.28. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, topping the consensus estimate of $7.64 by $0.19. The firm had revenue of $69.57 billion for the quarter, compared to the consensus estimate of $66.40 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same period last year, the firm posted $7.51 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Research analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be issued a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Thursday, December 4th. Cigna Group’s payout ratio is currently 26.64%.

Wall Street Analysts Forecast Growth

Several brokerages have commented on CI. Raymond James Financial reissued a “strong-buy” rating on shares of Cigna Group in a report on Monday, November 3rd. The Goldman Sachs Group dropped their price target on shares of Cigna Group from $370.00 to $330.00 and set a “buy” rating on the stock in a research note on Tuesday, November 4th. Weiss Ratings reissued a “hold (c+)” rating on shares of Cigna Group in a report on Wednesday, October 8th. Morgan Stanley reaffirmed an “overweight” rating and set a $355.00 price objective on shares of Cigna Group in a report on Friday, October 31st. Finally, Jefferies Financial Group reissued a “buy” rating and set a $310.00 target price on shares of Cigna Group in a research note on Monday, November 3rd. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $339.73.

Insider Activity

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the business’s stock in a transaction on Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the transaction, the insider owned 25,648 shares of the company’s stock, valued at approximately $7,694,400. The trade was a 52.66% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Brian C. Evanko sold 5,368 shares of the company’s stock in a transaction on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the sale, the insider owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. The trade was a 9.49% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 0.70% of the company’s stock.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.